BFSG LLC’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$197K Sell
6,538
-1,732
-21% -$55.7K 0.02% 277
2025
Q4
$258K Sell
8,270
-520
-6% -$12.8K 0.03% 240
2025
Q3
$178K Sell
8,790
-2,170
-20% -$38.1K 0.02% 286
2025
Q2
$184K Hold
10,960
0.02% 261
2025
Q1
$168K Buy
10,960
+790
+8% +$14.1K 0.02% 255
2024
Q4
$224K Sell
10,170
-745
-7% -$13.6K 0.03% 225
2024
Q3
$197K Sell
10,915
-2,490
-19% -$43.6K 0.02% 252
2024
Q2
$218K Sell
13,405
-1,275
-9% -$19.6K 0.03% 226
2024
Q1
$207K Hold
14,680
0.03% 234
2023
Q4
$153K Sell
14,680
-860
-6% -$8.03K 0.02% 269
2023
Q3
$159K Buy
+15,540
New +$145K 0.03% 234

Other funds holding TEVA